Johnson & Johnson's orthopedic activity: 3 notes


Here are three notes on Johnson & Johnson's orthopedic activity that Becker's has reported on since Oct. 9: 

1. Johson & Johnson is embarking on a two-year restructuring process of its orthopedic business after its third quarter earnings report reflected a shortfall in medical device sales.

2. Johnson & Johnson posted increases in third quarter revenue and orthopedic sales.

3. DePuy Synthes, Johnson and Johnson's orthopedic company, earned FDA 510(k) clearance for the TriALTIS spine system.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers